SELICK HAROLD E 4
4 · Protagonist Therapeutics, Inc · Filed Jan 13, 2026
Insider Transaction Report
Form 4
SELICK HAROLD E
Director
Transactions
- Exercise/Conversion
Common Stock
2026-01-09$4.21/sh+14,299$60,199→ 60,845 total - Exercise/Conversion
Stock Option (right to buy)
[F1]2026-01-09−14,299→ 0 totalExercise: $4.21Exp: 2026-04-29→ Common Stock (14,299 underlying)
Footnotes (1)
- [F1]These stock options are fully vested.
Signature
/s/ Matthew Gosling, Attorney-in-Fact for Harold E. Selick|2026-01-13